Nuvation Bio Inc.
HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
Last updated:
Abstract:
Aminopyrazine compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
Status:
Application
Type:
Utility
Filling date:
17 Jan 2020
Issue date:
23 Jul 2020